Stop by Booth #1135 at ASGCT 2024 to Discuss the Future of Cell and Gene Therapy!

By Mallory Griffin

KACTUS Booth #1135

Next week, KACTUS is thrilled to participate in the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) in Baltimore. This event, a significant gathering for the gene and cell therapy community, offers an ideal platform for showcasing our advanced gene editing enzymes and reagents. At KACTUS, our goal for the meeting is to engage with industry leaders and researchers, demonstrate our innovative GMP-grade gene editing enzymes and reagents, and foster collaborations that drive forward the potential of gene therapies. The ASGCT Annual Meeting serves as a pivotal forum for sharing research, advancing knowledge, and networking with experts across the field.

Poster #833

Transforming Tumor Research: Engineering MHCs as Versatile Reagents

Featured Products

MHC Monomers & Tetramers

AAV Titration ELISA Kits

AccuBase Cytosine Base Editor


Universal Cas9 ELISA Kit

GMP-Ready AsCas12a


Laminin 521

GMP-Grade MaxNuclease All-Purpose Endonuclease

Why attend the ASGCT Annual Meeting? 

With field-leading keynotes, 200+ scientific sessions, over 7,000 researchers in attendance, and an expanded exhibit hall, ASGCT 2024 is the nexus for gene and cell therapy discovery and networking. Register now to unlock the full educational and partnership potential of this premier event! 

Event Details: 

What: American Society of Gene & Cell Therapy 27th Annual Meeting 2024

When: May 7-11, 2024

Where: Baltimore Convention Center, Maryland

Booth: #1135


KACTUS excels in crafting and producing an array of superior-grade, highly active recombinant proteins and enzymes, catering to diverse sectors like antibody drug discovery, immunotherapy, gene therapy, and mRNA therapeutics. Our expansive catalog, boasting over 3000 recombinant proteins, encompasses a wide spectrum of targets, species, tags, and labels, each thoughtfully chosen to address the specific, unmet needs of scientists engaged in drug development. The hallmark of our product selection process is a rigorous emphasis on exceptional quality and a steadfast commitment to ensuring reliable supply, thereby upholding the highest standards of excellence and client satisfaction.